194 related articles for article (PubMed ID: 9705891)
21. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
[TBL] [Abstract][Full Text] [Related]
22. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
23. Hepatic disposition of the cytochrome P450 2E1 marker chlorzoxazone and its hydroxylated metabolite in isolated perfused rat livers.
Mehvar R; Vuppugalla R
J Pharm Sci; 2006 Jul; 95(7):1414-24. PubMed ID: 16724323
[TBL] [Abstract][Full Text] [Related]
24. Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats.
Khemawoot P; Yokogawa K; Shimada T; Miyamoto K
Biochem Pharmacol; 2007 Jan; 73(1):155-62. PubMed ID: 17049493
[TBL] [Abstract][Full Text] [Related]
25. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
[TBL] [Abstract][Full Text] [Related]
26. Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h.
Kim YC; Lee I; Kim SG; Ko SH; Lee MG; Kim SH
Life Sci; 2006 Nov; 79(23):2179-86. PubMed ID: 16914164
[TBL] [Abstract][Full Text] [Related]
27. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
[TBL] [Abstract][Full Text] [Related]
28. Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C.
Haufroid V; Ligocka D; Wallemacq P; Lison D; Horsmans Y
Toxicol Lett; 2005 Jan; 155(1):171-7. PubMed ID: 15585372
[TBL] [Abstract][Full Text] [Related]
29. Mammalian PC-12 cell genetically engineered for human cytochrome P450 2E1 expression.
Mapoles J; Berthou F; Alexander A; Simon F; Ménez JF
Eur J Biochem; 1993 Jun; 214(3):735-45. PubMed ID: 8391436
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory and noninhibitory monoclonal antibodies to human cytochrome P450 2E1.
Gelboin HV; Goldfarb I; Krausz KW; Grogan J; Korzekwa KR; Gonzalez FJ; Shou M
Chem Res Toxicol; 1996 Sep; 9(6):1023-30. PubMed ID: 8870991
[TBL] [Abstract][Full Text] [Related]
31. Ethanol-mediated transplacental induction of CYP2E1 in fetal rat liver.
Carpenter SP; Savage DD; Schultz ED; Raucy JL
J Pharmacol Exp Ther; 1997 Aug; 282(2):1028-36. PubMed ID: 9262372
[TBL] [Abstract][Full Text] [Related]
32. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.
Zhukov A; Ingelman-Sundberg M
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):453-8. PubMed ID: 10333489
[TBL] [Abstract][Full Text] [Related]
33. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats.
Shaik IH; Mehvar R
J Pharm Sci; 2011 Dec; 100(12):5281-92. PubMed ID: 21780121
[TBL] [Abstract][Full Text] [Related]
34. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
Zhou S; Paxton JW; Tingle MD; Kestell P
Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
[TBL] [Abstract][Full Text] [Related]
35. Human CYP2E1 mediates the formation of glycidamide from acrylamide.
Settels E; Bernauer U; Palavinskas R; Klaffke HS; Gundert-Remy U; Appel KE
Arch Toxicol; 2008 Oct; 82(10):717-27. PubMed ID: 18418580
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate.
Kent UM; Roberts ES; Chun J; Hodge K; Juncaj J; Hollenberg PF
Chem Res Toxicol; 1998 Oct; 11(10):1154-61. PubMed ID: 9778311
[TBL] [Abstract][Full Text] [Related]
37. Lack of constitutive and inducible ethoxyresorufin-O-deethylase activity in the liver of suckermouth armored catfish (Hypostomus affinis and Hypostomus auroguttatus, Loricariidae).
Parente TE; De-Oliveira AC; Beghini DG; Chapeaurouge DA; Perales J; Paumgartten FJ
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):252-60. PubMed ID: 19460462
[TBL] [Abstract][Full Text] [Related]
38. Is bupropion a more specific substrate for porcine CYP2E than chlorzoxazone and p-nitrophenol?
Skaanild MT; Friis C
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):159-62. PubMed ID: 17697034
[TBL] [Abstract][Full Text] [Related]
39. Characterization of CYP1A enzyme in Adélie penguin liver.
Wanwimolruk S; Wanwimolruk P
Comp Biochem Physiol C Toxicol Pharmacol; 2006 Oct; 144(2):148-54. PubMed ID: 16949883
[TBL] [Abstract][Full Text] [Related]
40. Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone.
Gorski JC; Jones DR; Wrighton SA; Hall SD
Xenobiotica; 1997 Mar; 27(3):243-56. PubMed ID: 9141232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
